Novartis AG
SIX:NOVN

Watchlist Manager
Novartis AG Logo
Novartis AG
SIX:NOVN
Watchlist
Price: 92.61 CHF 0.72% Market Closed
Market Cap: 181.2B CHF
Have any thoughts about
Novartis AG?
Write Note

Relative Value

The Relative Value of one NOVN stock under the Base Case scenario is 95.13 CHF. Compared to the current market price of 92.61 CHF, Novartis AG is Undervalued by 3%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NOVN Relative Value
Base Case
95.13 CHF
Undervaluation 3%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
12
vs Industry
29
Median 3Y
3.3
Median 5Y
3.2
Industry
2.6
Forward
4
vs History
73
vs Industry
33
Median 3Y
13.5
Median 5Y
14.2
Industry
23
Forward
13.1
vs History
17
vs Industry
29
Median 3Y
12.1
Median 5Y
12
Industry
17.8
vs History
65
vs Industry
22
Median 3Y
22.1
Median 5Y
20.3
Industry
25.4
vs History
7
vs Industry
14
Median 3Y
3.6
Median 5Y
3
Industry
2.2
vs History
12
vs Industry
26
Median 3Y
3.4
Median 5Y
3.6
Industry
2.8
Forward
4.2
vs History
12
vs Industry
35
Median 3Y
4.8
Median 5Y
5
Industry
5.4
vs History
36
vs Industry
33
Median 3Y
9.4
Median 5Y
9.7
Industry
13.7
Forward
10.5
vs History
50
vs Industry
28
Median 3Y
13.7
Median 5Y
14.8
Industry
17.2
Forward
12.2
vs History
23
vs Industry
28
Median 3Y
12.5
Median 5Y
12.6
Industry
16.5
vs History
26
vs Industry
21
Median 3Y
15.4
Median 5Y
15.4
Industry
19.3
vs History
9
vs Industry
29
Median 3Y
2
Median 5Y
1.7
Industry
2

Multiples Across Competitors

NOVN Competitors Multiples
Novartis AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
761.8B USD 18.5 90.9 48.9 54.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
368.4B USD 4.2 25 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
250.9B USD 4 20.6 10.4 12.5
CH
Roche Holding AG
SIX:ROG
208.8B CHF 3.6 18.2 10.2 12.1
UK
AstraZeneca PLC
LSE:AZN
158.6B GBP 4.1 31.3 169.3 253.7
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
US
Pfizer Inc
NYSE:PFE
151.8B USD 2.5 35.6 10.6 16
P/E Multiple
Earnings Growth
CH
Novartis AG
SIX:NOVN
Average P/E: 33.7
12.6
21%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25
-22%
US
Merck & Co Inc
NYSE:MRK
20.6
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
UK
AstraZeneca PLC
LSE:AZN
31.3
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A
US
Pfizer Inc
NYSE:PFE
35.6
733%

See Also

Discover More
Back to Top